ANDRÉS JESÚS
MUÑOZ MARTÍN
Profesor asociado de Ciencias de la Salud
Publicaciones (70) Publicaciones de ANDRÉS JESÚS MUÑOZ MARTÍN
2024
-
Chronological pattern of venous thromboembolism (VTE) occurrence impacts in survival of pancreatic ductal adenocarcinoma (PDAC)
Clinical and Translational Oncology
-
Improvement of thrombosis management in patients with cancer: a practical consensus document of recommendations for cancer-associated thrombosis patients’ healthcare in Spain
Clinical and Translational Oncology
-
Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group
Clinical and Translational Oncology, Vol. 26, Núm. 1, pp. 171-177
2023
-
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 2911-2925
-
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results from a Randomized, Open-Label, Phase III Trial
Journal of Clinical Oncology, Vol. 41, Núm. 11, pp. 2007-2019
-
Ambulatory cancer patients: who should definitely receive antithrombotic prophylaxis and who should never receive
Internal and Emergency Medicine, Vol. 18, Núm. 6, pp. 1619-1634
-
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
The Lancet, Vol. 402, Núm. 10415, pp. 1835-1847
-
Bleeding risk with concomitant administration of VEGF-TKIs and anticoagulant agents
Seminars in Oncology, Vol. 50, Núm. 3-5, pp. 67-70
-
Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer
Thrombosis Research, Vol. 232, pp. 133-137
-
Cost-effectiveness of apixaban and rivaroxaban in thromboprophylaxis of cancer patients treated with chemotherapy in Spain
Journal of Medical Economics, Vol. 26, Núm. 1, pp. 1145-1154
-
Development of a predictive model of venous thromboembolism recurrence in anticoagulated cancer patients using machine learning
Thrombosis Research, Vol. 228, pp. 181-188
-
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer
Thrombosis and Haemostasis
-
Ictus asociado a cáncer: estudio de prevalencia y factores predictores entre pacientes con ictus isquémico
Revista de neurologia, Vol. 76, Núm. 6, pp. 189-195
-
Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group
Clinical and Translational Oncology, Vol. 25, Núm. 10, pp. 3021-3031
-
Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet, Vol. 401, Núm. 10391, pp. 1853-1865
-
Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: Validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study
PLoS ONE, Vol. 18, Núm. 5 May
-
Reply to F.I. Mulder et al
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 36, pp. 5595
-
Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism
European Journal of Internal Medicine, Vol. 112, pp. 29-36
2022
-
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19
The Lancet Oncology, Vol. 23, Núm. 7, pp. e334-e347
-
Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer
Thrombosis and Haemostasis, Vol. 122, Núm. 5, pp. 796-807